Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Early hormone therapy for metastatic prostate cancer increases life expectancy

Men with aggressive, metastatic prostate cancer who receive immediate early hormone therapy live on average three to four years longer than others who delay similar treatment, according to researchers at the University of Rochester.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer

Men who take even small amounts of common cholesterol-lowering drugs such as Lovastatin and Simvastatin have a significantly reduced risk of prostate cancer, according to a new study by Oregon Health & Science University Cancer Institute researchers.

9 Jun 2004

Untreated prostate cancer can turn to lethal disease over long-term

New findings from a long-term study of men with early-stage, initially untreated prostate cancer suggests that the risk of progression to more aggressive and lethal disease increases significantly in the long-term, according to a study published in the June 9 issue of The Journal of the American Medical Association (JAMA).

9 Jun 2004

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.

7 Jun 2004

200 new therapies are being developed for prostate cancer

The Prostate Cancer Foundation (PCF) has announced that more than 200 new therapies are being developed for prostate cancer, many by researchers supported by the PCF. Substantially more prostate cancer therapies are in later stages of clinical development (Phases II and III) than ever before.

5 Jun 2004

Crucial discovery may help better diagnose and treat children with Hirschsprung disease

Researchers at Fox Chase Cancer Center have made a crucial discovery that may help physicians better diagnose and treat children with Hirschsprung disease, a debilitating and sometimes life-threatening ailment that causes bowel obstruction and involves an array of genetic changes.

5 Jun 2004

New method for identifying proteins found in trace quantities in the blood

Using conventional technologies, researchers supported by the National Cancer Institute (Science Applications International Corporation-Frederick, Inc. (SAIC)) have developed a new method for identifying proteins found in trace quantities in the blood.

5 Jun 2004

Smoking a lot more harmful than previously thought

The U.S. Surgeon General has released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body. Published 40 years after the surgeon general's first report on smoking -- which concluded that smoking was a definite cause of three serious diseases -- this newest report finds that cigarette smoking is conclusively linked to diseases such as leukemia, cataracts, pneumonia and cancers of the cervix, kidney, pancreas and stomach.

30 May 2004

Current test for prostate cancer is inadequate

Britain’s top cancer scientists claim that men’s health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.

27 May 2004

Smoking causes diseases in nearly every organ of the body

U.S. Surgeon General Richard H. Carmona today released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body.

27 May 2004

Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer returning

Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer coming back, regardless of whether the radiation was administered immediately after surgery or after the cancer recurred, according to a new study in the June 2004 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

27 May 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

3 or 4 glasses of wine a week can kill cancer cells

It’s well known that drinking red wine in moderation can have some health benefits, mainly attributed to a compound called resveratrol. Now, scientists at the University of Virginia Health System have discovered how.

25 May 2004

50 percent of British men admit they would delay seeing a doctor if they had warning signs of cancer

Younger men were most likely to cite embarrassment as a reason to delay getting their symptoms checked, whereas those in the 45+ age group were concerned about what the doctor might find as the result of an examination. Lack of time was a factor across all groups.

25 May 2004

Some people more at risk of obesity due to genetic makeup

Some people may have a higher risk of obesity because they are genetically predisposed to overeat or lead a sedentary lifestyle, a leading Cancer Research UK scientist will told conference delegates last week.

24 May 2004

Prostate Robotic System that will improve the diagnosis and treatment of prostate cancer

The Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a Prostate Robotic System that will improve the diagnosis and treatment of prostrate cancer, the fifth most common cancer in Singaporean men.

21 May 2004

Protein that appears to play a key role in Alzheimer's disease

A protein that allows human cancer to resist multiple anticancer drugs also appears to play a key role in Alzheimer's disease, according to research conducted at Fox Chase Cancer Center. The protein, active in brain tissue, could be a target for new drugs to treat patients with Alzheimer's.

20 May 2004

$First drug approved for hormone refractory prostate cancer that has shown a survival benefit$

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

The the Food and Drug Administration (FDA) approved Taxotere (docetaxel), injection in combination with prednisone ( a steroid), for the treatment of patients with advanced metastatic prostate cancer. This is the first drug approved for hormone refractory prostate cancer that has shown a survival benefit.

19 May 2004

Obesity epidemic and its impact on prostate cancer

Recent federal reports have identified obesity as epidemic in the United States, and that that greater body mass index can be associated with a number of debilitating health conditions, such as heart disease and diabetes.

12 May 2004